药物信息为Levalbuterol Hydrochloride (Mylan Pharmaceuticals Inc.): DESCRIPTION
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- ADVERSE REACTIONS (Adults and Adolescents =12 years old)
- ADVERSE REACTIONS (Children 6-11 years old)
- POSTMARKETING ADVERSE REACTIONS
- OVERDOSAGE
- HOW SUPPLIED
- STORAGE
- 外部链接相关的Levalbuterol Hydrochloride (Mylan Pharmaceuticals Inc.)
Levalbuterol Inhalation Solution, USP is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selective beta2-adrenergic receptor agonist (see CLINICAL PHARMACOLOGY). The chemical name for levalbuterol HCl is (R)-a1-[[(1,1-dimethylethyl) amino]methyl]-4-hydroxy-1,3-benzenedimethanol hydrochloride, and its established chemical structure is as follows:

The molecular weight of levalbuterol HCl is 275.8, and its molecular formula is C13H21NO3·HCl. It is a white to off-white, crystalline solid, with a melting point of approximately 187°C and solubility of approximately 180 mg/mL in water.
Levalbuterol HCl is the USAN modified name for (R)-albuterol HCl in the United States.
Levalbuterol Inhalation Solution, USP, Concentrate is supplied in 0.5 mL individually-wrapped unit-dose vials and should be diluted with sterile normal saline before administration by nebulization. Each 0.5 mL unit-dose vial contains 1.25 mg/0.5 mL (0.25%) of levalbuterol HCl, USP (as 1.44 mg of levalbuterol HCl), sodium chloride, USP to adjust tonicity and sulfuric acid NF to adjust the pH to 4.0 (3.3 to 4.5).
- Drug Information Provided by National Library of Medicine (NLM).
